0.31%QQQQ 43.45 
0.48%XLF 21.74 3.62%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
SCOTTSDALE, Ariz. - Medicis Pharmaceutical Corp. said Monday it will by privately held LipoSonix for $150 million in cash in a move to expand its aesthetics portfolio.
| MRX | 19.89 |  -0.23 |
Medicis makes a range of specialty pharmaceutical products to treat acne and skin conditions along with cosmetic dermal fillers. LipoSonix makes a system that uses ultrasound technology to remove unwanted fat. The product is not yet approved in the U.S., though Medicis expects it could enter the market by 2011.
The buyout deal also includes milestone payments up to an additional $150 million for LipoSonix upon Food and Drug Administration approval. Medicis said it will provide updated 2008 guidance when the deal closes.
Shares of Medicis closed unchanged at $22.72.
The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
The review was scathing. "She cannot sing very well," it said. "She is flat a go...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
